Marenzi G, Assanelli E, Marana I, Lauri G,Campodonico J, Grazi M
Transcription
Marenzi G, Assanelli E, Marana I, Lauri G,Campodonico J, Grazi M
Solmucol Comprimés effervescents Marenzi G, Assanelli E, Marana I, Lauri G,Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, et al. N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med.354: 2773-82; 2006. Tirouvanziam R, Conrad K. C, Bottiglieri T, Herzenberg A. L, Moss B. R, et al. High-dose oral N-Acetylcysteine, a glutathione prodrug,modulates inflammation in cystyc fibrosis. PNAS. 103: 4628-4633; 2006. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jensen M.H, MacNee W, Thomeer M, Wallaert B, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 353: 2229-42; 2005. Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure. A Randomized, Controlled Trial. Circulation.107: 992-995; 2003. Brophy F. D. Role of N-Acetylcysteine in the prevention of radiocontrast induced nephropathy. The Annals of Pharmacotherapy. 36: 1466-70; 2002. Russi E. W, Leuenberger Ph, Brändli O, Frey F. G, Grebski E, Gugger M, Paky A, Pons M, Karrer M, Kubn M, Rochat Th, Schibli R, Solèr M, Wacker F. Management of chronic obstructive pulmonary disease:the Swiss guidelines. SWISS MED WKLY. 132: 67-78; 2002. Poole J. P, Black N. P. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ. 322: 1-6; 2001. Stey C, Steurer J, Bachmann S, Medici T. C, Tramèr M. R. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. European Respiratory Journal.16: 253-262; 2000. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function byacetylcysteine. The New England Journal of Medicine. 180-184; 2000. Del Donno, M., Cacciani, G.C., Greco, F., Olivieri, D. N-Acetylcystein bei Patienten mit broncho-obstruktivem Syndrom. Therapiewoche Schweiz 7 (9): 628 - 632; 1991. Grasso, L., Mautone, G., Scarazatti, E., Lualdi, P. Les comprimés à sucer de N-acétylcystéine édulcorés au xylitol n'induisent pas la formation de plaque dentaire. Rev. Mens. Suisse Odontostomatol. 100: 617 - 619; 1990. De Bernardi di Valserra, M., Mautone, G., Barindelli, E., Lualdi, P., Feletti, F., Galmozzi, M.R. Bioavailability of suckable tablets of oral N-acetytylcysteine in man. Eur. J. Clin. Pharmacol. 37: 419 - 421; 1989. Copyright Fourtillan, J.B., Saux, M.C., Ingrand, I., Couraud, L. Influence de la N-acétylcystéine sur la diffusion de l'amoxicilline dans les tissus pulmonaires et bronchiques. J. Pharm. Clin. 9: 37 - 39; 1989. © 2013 IBSA Institut Biochimique SA